Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

Oncothyreon (ONTY +10.3%) spikes higher after Wedbush lifts its PT to $31 from $15 (implies a...

  • Wednesday, November 16, 2011, 2:01 PM ET
    Oncothyreon (ONTY +10.3%) spikes higher after Wedbush lifts its PT to $31 from $15 (implies a 300%+ gain), and argues shares have a "highly asymmetric" risk-reward going into the expected Q1 2012 release of Phase III trial data for its Stimuvax cancer vaccine. (previously)
Track new comments on this story

This news story has 3 comments:

  •  
    I'm seeing it at 4.14 down 7.38% unless I'm crazy?
    16 Nov 2011, 02:04 PM Reply Like
  •  
    Sorry, put the wrong ticker in. It's ONTY, now fixed.
    16 Nov 2011, 02:05 PM Reply Like
  •  
    Oh thanks :)
    16 Nov 2011, 02:06 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »